IMIM - Institut Hospital del Mar d'Investigacions Mèdiques IMIM - Institut Hospital del Mar d'Investigacions Mèdiques


Joaquim Bellmunt Molins, a genitourinary cancer specialist and a world leader in bladder and kidney cancer, is Director of Research at the Parc de Salut Mar (PSMAR) in Barcelona and director of the Hospital del Mar Medical Research Institute (IMIM) since November 2016.

Dr. Bellmunt was the head of the Solid Tumours section at Hospital del Mar from 2006 to 2013, leading the clinical research into genitourinary cancer at the IMIM. In March 2013, he was given the job of directing the Bladder Cancer Centre, a consortium comprising the Dana Farber Cancer Institute in Boston, one of the best cancer centres in the world, and the Brighman and Women's Hospital. During his time in the US, he was appointed associate professor of medicine at Harvard University.

He is a co-founder of the Spanish Group of Genitourinary Tumour Treatment and an advisor to the world's most prestigious publications in his speciality. He has authored more than 275 refereed articles and over 300 conference papers and book chapters. He is also a member of the American Society for Cancer Research and the American Association of Medical Oncology as well as being part of the scientific committee of the American Society of Clinical Genitourinary Oncology.

In Catalonia, he is an expert consultant in the design and development of the "Oncoguides" for CatSalut. His most important recent contribution was leading the international phase III study that revealed positive survival results for treatment with Pembrolizumab (immunotherapy) in advanced bladder cancer.


Joaquim Bellmunt Molins

Pilar Sánchez Macías(ELIMINAR)

93 316 07 80

93 316 04 10

Doctor Aiguader, 88
08003 Barcelona

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact